Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 6.95 is in line with its 5-year average of 7.16, near the low end of its 5-year range (3.22–25.32).
As of the fiscal period ended Tuesday, June 30, 2026. 32.54% above its 12-month average of 5.24.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 6.95.
QUICK RATIO (ACID-TEST)
6.95
QUICK RATIO (ACID-TEST) AVG TTM
5.24
QUICK RATIO (ACID-TEST) AVG 3Y
5.39
QUICK RATIO (ACID-TEST) AVG 5Y
7.16
QUICK RATIO (ACID-TEST) AVG 10Y
8.94
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+32.54%
CURRENT VS 3Y AVG
+28.92%
CURRENT VS 5Y AVG
-2.99%
CURRENT VS 10Y AVG
-22.31%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 608 covered companies
CURRENT VS SECTOR MEDIAN
+132.34%
vs the sector median at left
Definium Therapeutics, Inc.
Market Cap
$4.61B
Quick Ratio (Acid-Test)
6.95
TTM Avg
5.24
3Y Avg
5.39
5Y Avg
7.16
Market Cap
$4.64B
Quick Ratio (Acid-Test)
1.38
TTM Avg
1.51
3Y Avg
1.37
5Y Avg
1.40
Market Cap
$4.69B
Quick Ratio (Acid-Test)
11.31
TTM Avg
9.52
3Y Avg
6.89
5Y Avg
6.89
Market Cap
$4.45B
Quick Ratio (Acid-Test)
4.68
TTM Avg
3.02
3Y Avg
3.88
5Y Avg
4.28
Market Cap
$4.73B
Quick Ratio (Acid-Test)
26.10
TTM Avg
14.27
3Y Avg
14.23
5Y Avg
14.47
Market Cap
$4.82B
Quick Ratio (Acid-Test)
2.74
TTM Avg
2.74
3Y Avg
3.13
5Y Avg
4.87
Market Cap
$4.35B
Quick Ratio (Acid-Test)
5.08
TTM Avg
3.83
3Y Avg
4.06
5Y Avg
4.06
Market Cap
$4.38B
Quick Ratio (Acid-Test)
0.66
TTM Avg
0.63
3Y Avg
0.81
5Y Avg
1.13
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Definium Therapeutics, Inc. (DFTX) | $4.61B | 6.95 | 5.24 | 5.39 | 7.16 |
| LifeStance Health Group, Inc. (LFST)vs › | $4.64B | 1.38 | 1.51 | 1.37 | 1.40 |
| BillionToOne, Inc. (BLLN)vs › | $4.69B | 11.31 | 9.52 | 6.89 | 6.89 |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.45B | 4.68 | 3.02 | 3.88 | 4.28 |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.73B | 26.10 | 14.27 | 14.23 | 14.47 |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.82B | 2.74 | 2.74 | 3.13 | 4.87 |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.35B | 5.08 | 3.83 | 4.06 | 4.06 |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.38B | 0.66 | 0.63 | 0.81 | 1.13 |
| Erasca, Inc. (ERAS)vs › | $4.89B | 8.29 | 9.94 | 10.32 | 11.01 |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.24B | 16.24 | 19.89 | 20.20 | 22.94 |
Quick Ratio
6.95
Excludes inventory
Current Ratio
6.95
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 6.95 |
| 2026-03-31 | 4.69 |
| 2025-12-31 | 6.29 |
| 2025-09-30 | 3.30 |
| 2025-06-30 | 4.98 |
| 2025-03-31 | 7.27 |
| 2024-12-31 | 7.25 |
| 2024-09-30 | 9.00 |
| 2024-06-30 | 5.92 |
| 2024-03-31 | 3.91 |
| 2023-12-31 | 3.22 |
| 2023-09-30 | 3.85 |
| 2023-06-30 | 3.41 |
| 2023-03-31 | 5.50 |
| 2022-12-31 | 8.16 |
| 2022-09-30 | 6.01 |
| 2022-06-30 | 13.86 |
| 2022-03-31 | 11.67 |
| 2021-12-31 | 13.18 |
| 2021-09-30 | 25.32 |
| 2021-06-30 | 14.80 |
| 2021-03-31 | 25.16 |
| 2020-12-31 | 27.10 |
| 2020-09-30 | 4.67 |
| 2020-06-30 | 11.82 |
| 2020-03-31 | 8.86 |
| 2019-08-31 | 14.76 |
| 2019-05-31 | 0.60 |
| 2019-02-28 | 1.24 |
| 2018-11-30 | 0.59 |
| 2018-08-31 | 24.14 |
| 2018-05-31 | 5.05 |
| 2018-02-28 | 7.86 |
| 2017-11-30 | 14.99 |
| 2017-08-31 | 6.60 |
| 2017-05-31 | 13.05 |
| 2017-02-28 | 46.45 |
| 2016-11-30 | 13.98 |
